Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma, Stage II, Stage I”

234 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 234 results

Not applicableLooking for participantsNCT06643286
What this trial is testing

Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma

Who this might be right for
Melanoma (Skin)Melanoma, Stage II, Stage IMelanoma Stage+1 more
Erasmus Medical Center 180
Testing effectiveness (Phase 2)Looking for participantsNCT05423262
What this trial is testing

TRK-950 in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorMelanoma
Toray Industries, Inc 49
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Not applicableStudy completedNCT02975700
What this trial is testing

PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma

Who this might be right for
Melanoma
Daiichi Sankyo Co., Ltd. 6
Testing effectiveness (Phase 2)Temporarily pausedNCT01988831
What this trial is testing

Efficacy of Propranolol Treatment to Prevent Melanoma Progression

Who this might be right for
Stages III Skin MelanomaStages II Skin MelanomaStage IB Skin Melanoma
University Hospital, Geneva 450
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Ended earlyNCT00496223
What this trial is testing

A Phase I/II Study of Sunitinib and Dacarbazine

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 11
Early research (Phase 1)Study completedNCT01138085
What this trial is testing

Safety, Pharmacokinetics (PK) of AKT and MEK Combination

Who this might be right for
Cancer
GlaxoSmithKline 240
Testing effectiveness (Phase 2)Looking for participantsNCT02332668
What this trial is testing

Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Who this might be right for
MelanomaLymphomaSolid Tumor+2 more
Merck Sharp & Dohme LLC 370
Testing effectiveness (Phase 2)Study completedNCT00005815
What this trial is testing

Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00680589
What this trial is testing

Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT04789668
What this trial is testing

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Hematopoietic and Lymphoid Cell Neoplasm+11 more
M.D. Anderson Cancer Center 8
Not applicableStudy completedNCT01703585
What this trial is testing

Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples

Who this might be right for
Colorectal CancerBreast CancerGynecological Cancer+3 more
University Health Network, Toronto 45
Testing effectiveness (Phase 2)Ended earlyNCT01082887
What this trial is testing

Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg)

Who this might be right for
Metastatic Melanoma
Nantes University Hospital 18
Testing effectiveness (Phase 2)Study completedNCT02570308
What this trial is testing

The Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma

Who this might be right for
Uveal Melanoma
Immunocore Ltd 146
Early research (Phase 1)Study completedNCT00559026
What this trial is testing

Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients

Who this might be right for
Melanoma
Istituto Superiore di Sanità 10
Testing effectiveness (Phase 2)WithdrawnNCT02143050
What this trial is testing

Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients

Who this might be right for
Melanoma
University of Louisville
Testing effectiveness (Phase 2)Study completedNCT01065441
What this trial is testing

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

Who this might be right for
Solid Tumors Stage II, Stage III and Stage IVBreast CancerColorectal Cancer+5 more
Michael Har-Noy 9
Testing effectiveness (Phase 2)UnknownNCT00538005
What this trial is testing

Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
San Diego Pacific Oncology & Hematology Associates 54
Testing effectiveness (Phase 2)Study completedNCT00003895
What this trial is testing

Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma

Who this might be right for
Recurrent MelanomaStage IA MelanomaStage IB Melanoma+6 more
National Cancer Institute (NCI) 36
Next Page